Intervention Effect of High Definition Transcranial Direct Current Stimulation (HD-tDCS) on Anxiety Disorder

Launched by ANHUI MEDICAL UNIVERSITY · Mar 17, 2022

Keywords

ClinConnect Summary

This clinical trial is exploring a treatment called high definition transcranial direct current stimulation (HD-tDCS) to see how it affects anxiety symptoms in individuals with anxiety disorders. The goal is to understand not only if this treatment can help relieve anxiety but also to learn more about how it works in the brain using MRI scans. The study is currently looking for participants aged 18 to 60 years who have been diagnosed with anxiety by multiple psychiatrists and meet certain criteria for anxiety severity.

To be eligible, participants should have normal vision and be right-handed, and they must be able to complete various tests required for the study. However, those with severe physical illnesses, other neurological conditions, or who are pregnant cannot participate. If you decide to take part, you can expect to receive this non-invasive treatment and undergo some brain imaging to help researchers better understand the effects. Your participation could contribute valuable information to the field of anxiety treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • the patients were diagnosed by more than 2 psychiatrists and met the diagnostic criteria of DSM-5 for anxiety, and HAMA\>14, PHQ-15\>5.
• • the age ranged from 18 to 60 years old, and the length of education was more than 5 years.
• • the visual acuity or corrected visual acuity is normal, right-handed, can cooperate with the completion of various experimental tests.
• Exclusion Criteria:
• • accompanied by severe somatic diseases, such as severe heart, liver, renal insufficiency and so on.
• • accompanied by other neurological diseases, such as stroke, epilepsy and so on.
• • pregnant and lactating women.
• • accompanied by other mental disorders, such as drug abuse, schizophrenia, schizophrenic affective disorder, hysteria, autism and so on.
• • patients with MRI taboos or factors affecting imaging quality, such as cardiac pacemaker, cochlear implant, cardio-cerebrovascular metal stent, metal denture, etc.
• • those who could not cooperate with those who completed the relevant experiments, such as patients with depressive stupor, claustrophobia and so on.